PECAM1 and cancer: Different studies have shown that phloretin significantly affects the activity of cancer stem cells via targeting different stemness pathways and markers, such as ALDH 1, CD44, CD31, VEGF, Sox-2 etc., thereby diminishing the clonal property of cancer stem cells and reducing angiogenesis, tumor growth, and metastasis [11,16,17].